Pfizer (PFE) Shares Surge 13% Following Game-Changing COVID-19 Pill Data, Merck (MRK) Down 9%; Analyst Sees Oral Antiviral Market Totaling 'Tens of Billion of Dollars Annually'
Tweet Send to a Friend
Pfizer (NYSE: PFE) shares are up 13% in pre-open Friday after the company presented testing data of its COVID-19 oral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
